John C. Martin, 69, Dies; Led Drugmaker in Breakthroughs
A chemist by training, he turned Gilead Sciences into a leading, and lucrative, innovator with single-pill treatments for H.I.V. and hepatitis C.
by ·
A chemist by training, he turned Gilead Sciences into a leading, and lucrative, innovator with single-pill treatments for H.I.V. and hepatitis C.
by · Published June 1, 2021
by · Published June 11, 2021
by · Published June 5, 2021








